Study
|
Location
|
Overall prevalence rate
|
Prevalence rate in older age group
|
Surveys of treated patients |
RCGP (1958) | UK national data | 3/1000 | – |
Gibsonet al (1966)
| Rural cohort, USA | 9-10/1000 | 65/1000 (>65 years) |
RCGP (1986) | UK national data | 11/1000 | – |
Parameshwar et al (1992)
| London, UK | 4/1000 | 28/1000 (> 65 years) |
Rodeheffer (1993) | Rochester, UK | 3/1000 (< 75 years) | – |
Mair et al (1994) | Liverpool, UK | 15/1000 | 80/1000 (> 65 years) |
RCGP (1995) | UK national data | 9/1000 | 74/1000 (65–74 years) |
Clarkeet al (1995) | Nottinghamshire, UK | 8-16/1000 | 40–60/1000 (> 70 years) |
Population screening |
Droller and Pemberton (1953) | Sheffield, UK | – | 30-50/1000 (> 62 years) |
Garrisonet al (1966)
| Georgia, USA | 21/1000 (45–74 years) | 35/1000 (65–74 years) |
Framingham (1971) | Framingham, USA | 3/1000 (< 63 years) | 23/1000 (60-79 years) |
Landahl et al (1984) | Sweden (males only) | 3/1000 (< 75 years) | 80–170/1000 (> 67 years) |
Eriksson et al (1989)
| Gothenburg, Sweden | – | 130/1000 (> 67 years) |
NHANES (1992) | USA national data | 20/1000 | 80/1000 (> 65 years) |
Cardiovascular health study (1993) | USA national data | 20/1000 | 80/1000 (> 65 years) |
RCGP (1995) | UK national data | 9/1000 (25–74 years) | 74/1000 (65–74 years) |